MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with ...

Waltham, Massachusetts Friday, November 15, 2024, 15:00 Hrs [IST] ...

Cereno Scientific has secured loan financing to continue developing CS1, its lead therapeutic candidate for pulmonary ...

United Therapeutics posts impressive Q3 results, driven by Tyvaso, Orenitram, and Unituxin. See why UTHR stock is a buy and ...

Liquidia's collaboration on L606 boosts long-term growth potential. Find out why LQDA stock’s valuation and upcoming launches ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company ...

Gyre Therapeutics Inc ( (GYRE) ) has released its Q3 earnings. Here is a breakdown of the information Gyre Therapeutics Inc presented to its ...

EXCLUSIVE: The Industrial Injuries Advisory Council is advising ministers to offer this support to Covid victims still ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on high-purity ...

Researchers are trying to get to the root of the problem, in hopes of helping these patients who are suffering the longest.

There are many possible causes for coughing up blood, including acute infections like bronchitis, chronic conditions like cystic fibrosis, a chest or lung injury, pulmonary embolism (blood clot in the ...